Current research into cancer drugs
For the past 120 years, we’ve been making discoveries that have saved countless lives. But we have so much more to do. Our strategy sets out how we'll accelerate progress towards a better future.
Saving lives through our research
From the underpinning research that can lead to new treatments, to developing drugs for patients, our researchers are working hard to find new ways to tackle cancer. Below are some examples of what our researchers are doing right now.
Our current researchers
Taking on a mutated gene
Professor Ian Hitchcock in York is focusing on faulty versions of a gene called JAK2 that's found in a group of blood cancers called myloproliferative neoplasms. He's already found that the mutated version of JAK2 only works if it can act through a specific molecule called MPL. And as there are already drugs that can affect MPL, he believes that by targeting the molecule with drugs he can indirectly stop the effects of faulty JAK2, stopping these blood cancers in their tracks.
On the path of TRAIL
Professor Henning Walczak in London is working to target a cell death pathway triggered by a molecule in cells called TRAIL. He's investigating if targeting molecules in the pathway could work as a treatment for certain cancers where the TRAIL pathway is faulty. This could lead to the development of new treatments for people with these cancers.